Ieq Capital LLC Purchases 11,666 Shares of Colgate-Palmolive (NYSE:CL)

Ieq Capital LLC boosted its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 25.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 58,008 shares of the company's stock after acquiring an additional 11,666 shares during the quarter. Ieq Capital LLC's holdings in Colgate-Palmolive were worth $5,274,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in CL. Swedbank AB grew its holdings in Colgate-Palmolive by 1.4% during the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company's stock worth $306,246,000 after acquiring an additional 40,324 shares during the last quarter. Sequoia Financial Advisors LLC grew its holdings in Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company's stock worth $2,117,000 after acquiring an additional 113 shares during the last quarter. Private Advisor Group LLC grew its holdings in Colgate-Palmolive by 5.4% during the 3rd quarter. Private Advisor Group LLC now owns 68,952 shares of the company's stock worth $7,158,000 after acquiring an additional 3,543 shares during the last quarter. International Assets Investment Management LLC lifted its position in Colgate-Palmolive by 13,776.8% during the 3rd quarter. International Assets Investment Management LLC now owns 435,871 shares of the company's stock valued at $45,248,000 after purchasing an additional 432,730 shares during the period. Finally, Hennion & Walsh Asset Management Inc. lifted its position in Colgate-Palmolive by 4.2% during the 3rd quarter. Hennion & Walsh Asset Management Inc. now owns 20,975 shares of the company's stock valued at $2,177,000 after purchasing an additional 851 shares during the period. Institutional investors own 80.41% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research report on Monday, February 3rd. Finally, Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $101.16.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $89.56 on Friday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The company has a market capitalization of $72.68 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. The company's 50 day moving average price is $88.94 and its two-hundred day moving average price is $95.91. Colgate-Palmolive has a 52 week low of $84.45 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the company posted $0.87 EPS. On average, analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive's dividend payout ratio is currently 56.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.